LRI Investments LLC Sells 500 Shares of Doximity, Inc. (NASDAQ:DOCS)

LRI Investments LLC reduced its holdings in shares of Doximity, Inc. (NASDAQ:DOCS) by 39.8% during the fourth quarter, HoldingsChannel.com reports. The fund owned 756 shares of the company’s stock after selling 500 shares during the quarter. LRI Investments LLC’s holdings in Doximity were worth $40,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also bought and sold shares of the business. Iron Triangle Partners LP bought a new stake in Doximity during the fourth quarter worth $16,688,000. Graham Capital Management L.P. bought a new stake in Doximity during the fourth quarter worth $1,797,000. Fundsmith LLP bought a new stake in Doximity during the fourth quarter worth $37,934,000. D. E. Shaw & Co. Inc. lifted its holdings in Doximity by 180.4% during the fourth quarter. D. E. Shaw & Co. Inc. now owns 972,157 shares of the company’s stock worth $51,903,000 after acquiring an additional 625,467 shares during the period. Finally, Cresset Asset Management LLC increased its position in Doximity by 24.0% in the fourth quarter. Cresset Asset Management LLC now owns 64,732 shares of the company’s stock worth $3,456,000 after buying an additional 12,538 shares during the last quarter. 87.19% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, Director Kira Scherer Wampler sold 2,000 shares of the business’s stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $56.93, for a total transaction of $113,860.00. Following the completion of the transaction, the director now directly owns 16,618 shares in the company, valued at $946,062.74. The trade was a 10.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Anna Bryson sold 45,000 shares of the business’s stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $57.23, for a total value of $2,575,350.00. Following the transaction, the chief financial officer now owns 357,165 shares of the company’s stock, valued at approximately $20,440,552.95. The trade was a 11.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. 37.40% of the stock is owned by company insiders.

Doximity Stock Performance

Shares of NASDAQ DOCS opened at $60.38 on Wednesday. The stock has a market cap of $11.27 billion, a PE ratio of 60.38, a price-to-earnings-growth ratio of 4.10 and a beta of 1.41. Doximity, Inc. has a fifty-two week low of $23.27 and a fifty-two week high of $85.21. The stock has a fifty day moving average of $57.71 and a 200-day moving average of $57.52.

Analysts Set New Price Targets

A number of analysts have issued reports on DOCS shares. KeyCorp decreased their target price on Doximity from $83.00 to $70.00 and set an “overweight” rating for the company in a research report on Wednesday, April 16th. Wells Fargo & Company reissued an “equal weight” rating on shares of Doximity in a research report on Friday, February 7th. Raymond James reissued an “outperform” rating and issued a $83.00 target price (up from $65.00) on shares of Doximity in a research report on Friday, February 7th. Leerink Partners raised Doximity from a “market perform” rating to an “outperform” rating and raised their target price for the stock from $60.00 to $90.00 in a research report on Friday, February 7th. Finally, Needham & Company LLC raised their target price on Doximity from $65.00 to $82.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. Eleven equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $65.39.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.